These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21867583)

  • 41. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.
    Suh CO; Shim SJ; Lee SW; Yang WI; Lee SY; Hahn JS
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):228-33. PubMed ID: 16503386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?
    Garden AS; Asper JA; Morrison WH; Schechter NR; Glisson BS; Kies MS; Myers JN; Ang KK
    Cancer; 2004 Mar; 100(6):1171-8. PubMed ID: 15022283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intestinal marginal zone B-cell lymphoma of MALT type: clinical manifestation and outcome of a rare disease.
    Oh SY; Kwon HC; Kim WS; Hwang IG; Park YH; Kim K; Ko YH; Ryoo BY; Kang HJ; Nam E; Lee JH; Kim JH; Kim HJ
    Eur J Haematol; 2007 Oct; 79(4):287-91. PubMed ID: 17692101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphoma of the thyroid and head and neck.
    Beasley MJ
    Clin Oncol (R Coll Radiol); 2012 Jun; 24(5):345-51. PubMed ID: 22475637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension.
    Harb WJ; Luna MA; Patel SR; Ballo MT; Roberts DB; Sturgis EM
    Head Neck; 2007 Aug; 29(8):731-40. PubMed ID: 17274049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical features of mucosa-associated lymphoid tissue lymphoma in head and neck].
    Diao WW; Zhu YY; Zhu XL; Li WY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 33(4):362-366. PubMed ID: 30970411
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical and pathologic characterization of mucosa-associated lymphoid tissue lymphoma of the head and neck.
    Bhattacharyya N; Frankenthaler RA; Gomolin HI; Kadin ME; Lauretano AM
    Ann Otol Rhinol Laryngol; 1998 Sep; 107(9 Pt 1):801-6. PubMed ID: 9749552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG).
    Sammassimo S; Pruneri G; Andreola G; Montoro J; Steffanoni S; Nowakowski GS; Gandini S; Negri M; Habermann TM; Raderer M; Li ZM; Zinzani PL; Adam P; Zucca E; Martinelli G
    Hematol Oncol; 2016 Dec; 34(4):177-183. PubMed ID: 26152851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suggestion of response evaluation criteria in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML).
    Jung SK; Paik JS; Jung SE; Park G; Choi BO; Oh JK; Park YG; Yang SW; Cho SG
    Ann Hematol; 2015 Jul; 94(7):1185-93. PubMed ID: 25728714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study.
    Koh MS; Kim WS; Kim SJ; Oh SY; Yoon DH; Lee SI; Hong J; Song MK; Shin HJ; Kwon JH; Kim HJ; Do YR; Suh C; Kim HJ
    Int J Hematol; 2015 Oct; 102(4):420-5. PubMed ID: 26210384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dissemination pattern of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.
    Ishii Y; Tomita N; Suzuki T; Ishiyama Y; Kishimoto K; Yamamoto E; Koyama S; Hattori Y; Nakajima Y; Motohashi K; Takasaki H; Kawasaki R; Hashimoto C; Takemura S; Fujimaki K; Fujita H; Sakai R; Fujisawa S; Motomura S; Ishigatsubo Y
    Leuk Lymphoma; 2015; 56(9):2750-2. PubMed ID: 25644745
    [No Abstract]   [Full Text] [Related]  

  • 53. Low-dose radiotherapy (2×2 g) versus low doses and rituximab in the treatment of marginal zone b-cell lymphoma previously untreated.
    Aviles A; Cleto S
    Leuk Res; 2020 Nov; 98():106443. PubMed ID: 32980580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphoma.
    Gao LR; Wang X; Wu Y; Feng XL; Rao W; Liu X; Song YW; Fang H; Chen B; Jin J; Liu YP; Jing H; Tang Y; Lu NN; Li N; Zhang WW; Zhai Y; Wang SL; Qi SN; Li YX
    Leuk Lymphoma; 2024 Jun; 65(6):746-757. PubMed ID: 38506231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mucosa-associated lymphoid tissue lymphoma of the breast: bilateral metachronous presentation.
    Zumsteg ZS; Ng AK
    Leuk Lymphoma; 2010 Jan; 51(1):168-70. PubMed ID: 19886841
    [No Abstract]   [Full Text] [Related]  

  • 56. Follow-up in head and neck cancer: patients' perspective.
    Trinidade A; Kothari P; Andreou Z; Hewitt RJ; O'Flynn P
    Int J Health Care Qual Assur; 2012; 25(2):145-9. PubMed ID: 22455179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and prognostic features of lymphomas arising in the head and neck region: Our experience of preferential association of different histotypes with various sites of origin in ninety patients.
    Bussu F; Hohaus S; Bastanza G; Bozzoli V; Tisi MC; Martini M; Paludetti G; Almadori G
    Clin Otolaryngol; 2013 Jun; 38(3):248-53. PubMed ID: 23374252
    [No Abstract]   [Full Text] [Related]  

  • 58. Critical review of the follow-up protocol for head and neck cancer patients.
    Kytö E; Haapio E; Minn H; Irjala H
    J Laryngol Otol; 2019 May; 133(5):424-429. PubMed ID: 31006389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignant lymphomas of the head and neck--a retrospective study of 75 patients.
    Motoori T; Mihashi K; Sueyoshi F; Mihashi S; Hirano M
    Kurume Med J; 1982; 29 Suppl():S179-94. PubMed ID: 7132277
    [No Abstract]   [Full Text] [Related]  

  • 60. The lasting impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study.
    Taylor R; Khan A; Omakobia E; Sood S
    J Laryngol Otol; 2023 May; 137(5):537-540. PubMed ID: 36789959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.